Erin Burkhart serves as Executive at BIOMARIN PHARMACEUTICAL INC, where they oversee executive responsibilities. Since joining the company, Erin Burkhart has executed 8 insider transactions totaling $270.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 13, 2024 involved selling 714 shares valued at $64.3K.
Erin Burkhart currently holds 14,449 shares of BIOMARIN PHARMACEUTICAL INC (BMRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erin Burkhart has been a net seller of BMRN stock. They have purchased $0 and sold $270.0K worth of shares.
Erin Burkhart's most recent insider trade was on Aug 13, 2024, when they sold 714 shares at $90.00 per share.
Get notified when new Form 4 filings are submitted
| $76.97 |
| Discretionary |
| Apr 10, 2024 | BMRN | $205.7K | Sale | 2,286 | $90.00 | Planned |
| Mar 18, 2024 | BMRN | $31.2K | Payment | 372 | $83.87 | Discretionary |
| Mar 15, 2024 | BMRN | $0 | Award | 4,720 | $N/A | Discretionary |
| May 16, 2023 | BMRN | $73.2K | Payment | 796 | $92.02 | Discretionary |
| Mar 15, 2023 | BMRN | $0 | Award | 3,760 | $N/A | Discretionary |
| May 16, 2022 | BMRN | $0 | Award | 11,130 | $N/A | Discretionary |